Entrada Therapeutics, Inc.

NASDAQ:TRDA

Biotechnology

Healthcare
$4.96 +0.37%

+$0.03 today

Market cap
$194.19M
Beta
-0.26
P/E (TTM)
-1.7
EPS (TTM)
-$3.97
52W Low $4.93High $16.45

Volume 0.43M

Average 0.36M

Price history

Entrada Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-43.76%

Period high

$16.03

Period low

$4.37

Latest

$4.96

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
8-KOct 14, 2026Oct 14, 2026
SC 13D/ASep 10, 2026Sep 10, 2026
4Sep 9, 2026Sep 9, 2026
4Sep 9, 2026Sep 9, 2026
4Sep 3, 2026Sep 3, 2026
4Sep 3, 2026Sep 3, 2026
4Sep 3, 2026Sep 3, 2026
4Sep 3, 2026Sep 3, 2026
4Sep 3, 2026Sep 3, 2026
4Sep 3, 2026Sep 3, 2026
4Aug 31, 2026Aug 31, 2026
4Aug 31, 2026Aug 31, 2026
4Aug 26, 2026Aug 26, 2026

Competitors

Who does Entrada Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about TRDA's filings, answered from its disclosures.

What is the latest TRDA filing?

The latest filing shown is 10-Q dated Nov 5, 2026.

How many recent filings does TRDA have?

Intrinsic Alpha currently shows 20 recent filings for TRDA.